Wonbiogen Co., Ltd. (307280) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Wonbiogen Co., Ltd. (307280:KRX), powered by AI.

Current Price
₩6,260
P/E Ratio
6.7
Market Cap
44.4B
Sector
Healthcare
What is the Wonbiogen Co., Ltd. stock price forecast?

Wonbiogen Co., Ltd. is currently trading at ₩6,260. View real-time AI analysis on Alpha Lenz.

What is Wonbiogen Co., Ltd. insider trading activity?

View the latest insider trading data for Wonbiogen Co., Ltd. on Alpha Lenz.

What is Wonbiogen Co., Ltd.'s P/E ratio?

Wonbiogen Co., Ltd.'s P/E ratio is 6.7.

Wonbiogen Co., Ltd.

KRX · 307280
₩6,260-40(-0.63%)Market closedKRX regular session 09:00–15:30 KST
Ask about Wonbiogen Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Wonbiogen Co., Ltd. trades at a P/E of 6.7 (undervalued) with strong ROE of 16.6%. Operating margin of 23.2% indicates strong profitability.

Ask for details

Company Overview

Wonbiogen Co., Ltd. is a biotechnology company that focuses on the research, development, and commercialization of innovative biopharmaceutical products. Primarily engaged in creating therapeutic solutions, the company targets major disease areas, including oncology and metabolic disorders, aiming to address unmet medical needs. Renowned for its investment in cutting-edge technology, Wonbiogen integrates advanced research methodologies to enhance its drug discovery and development processes. The company's products, which often stem from its pipeline of new molecule entities, are instrumental in advancing medical innovation within the healthcare sector. By continually expanding its research and strategic partnerships, Wonbiogen plays a significant role in the biopharmaceutical landscape, influencing both domestic and international markets with its robust portfolio of therapeutic solutions. With a commitment to improving patient health outcomes, the company underscores its market significance through ongoing contributions to scientific advancement and healthcare delivery.

CEO김원일
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees76

Company Statistics

FY 2025

Profile

₩44,412,365,020Market Cap
₩35,244,285,940Revenue
7.09MShares Out
76Employees

Margins

50.55%Gross
28.25%EBITDA
23.24%Operating
22.08%Pre-Tax
18.33%Net

Valuation

6.71P/E
1.04P/B
1.26EV/Sales
3.71EV/EBITDA
6.87P/FCF

Growth (CAGR)

9.63%Rev 3Yr
24.01%Rev 5Yr
16.73%Op Inc 3Yr
26.87%Op Inc 5Yr
25.44%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

14.53%ROA
16.55%ROE
17.60%ROIC

Financial Health

₩8,259,823,840Cash & Cash Equivalents
₩-3,257,963,900Net Debt
11.73%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Wonbiogen Co., Ltd. (ticker: 307280) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 76 employees. Market cap is $44.4B.

The current price is ₩6,260 with a P/E ratio of 6.71x and P/B of 1.04x.

ROE is 16.55% and operating margin is 23.24%. Annual revenue is $35.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Wonbiogen Co., Ltd. (307280) Stock Forecast 2026 ₩6,260 — Price, Financials & Analyst Targets | Alpha Lenz